LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Medicine recalls, shortages and safety updates in the UK

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 27 Sep 2026 13:39.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

15 Jul 2026Wednesday 15 July 2026

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Botulinum toxin type A products
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients…
What this means, batches, details

Loading…

13 Jul 2026Monday 13 July 2026

open day ◀ ▶ 1 event · 1 important
Medicines recall ChloraPrep 1mL Applicator
Class 2 recall · DMRC - 40102707 · PL: 05920/0002 · Beckton Dickson UK Ltd · Chlorhexidine gluconate 2%w/v and isopropyl alcohol 70% v/v
What this means, batches, details

Loading…

9 Jul 2026Thursday 9 July 2026

open day ◀ ▶ 1 event · 1 important
Class 2 recall · DMRC-40025785 · PL: 17907/0249 · Bristol Laboratories Limited · phenoxymethylpenicillin potassium
Batches: 7124002 (11/2026)
What this means, batches, details

Loading…

6 Jul 2026Monday 6 July 2026

open day ◀ ▶ 1 event
MHRA approval Retifanlimab (ZYNYZ)
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.  
What this means, batches, details

Loading…

1 Jul 2026Wednesday 1 July 2026

open day ◀ ▶ 1 event
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.  
What this means, batches, details

Loading…

In total 282 events.